KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Elevance Health (ELV) Cost of Revenue (2016 - 2025)

Elevance Health (ELV) has disclosed Cost of Revenue for 17 consecutive years, with $132.6 billion as the latest value for Q4 2025.

  • On a quarterly basis, Cost of Revenue rose 278.38% to $132.6 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $148.2 billion, a 650.5% increase, with the full-year FY2025 number at $148.2 billion, up 650.5% from a year prior.
  • Cost of Revenue was $132.6 billion for Q4 2025 at Elevance Health, up from $5.4 billion in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $132.6 billion in Q4 2025 to a low of -$74.3 billion in Q4 2024.
  • A 5-year average of $21.6 billion and a median of $26.5 billion in 2021 define the central range for Cost of Revenue.
  • Peak YoY movement for Cost of Revenue: surged 1930.57% in 2021, then tumbled 1636.43% in 2024.
  • Elevance Health's Cost of Revenue stood at $51.2 billion in 2021, then plummeted by 40.94% to $30.2 billion in 2022, then tumbled by 84.01% to $4.8 billion in 2023, then crashed by 1636.43% to -$74.3 billion in 2024, then soared by 278.38% to $132.6 billion in 2025.
  • Per Business Quant, the three most recent readings for ELV's Cost of Revenue are $132.6 billion (Q4 2025), $5.4 billion (Q3 2025), and $5.3 billion (Q2 2025).